Literature DB >> 338412

Pancreatic injury following ERCP. Failure of prophylactic benefit of Trasylol.

R Brust, A B Thomson, R H Wensel, R W Sherbaniuk, L Costopoulos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 338412     DOI： 10.1016/s0016-5107(77)73457-1

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN： 0016-5107            Impact factor:   9.427


× No keyword cloud information.
  6 in total

Review 1.  Effectiveness and tolerability of NSAIDs in the prophylaxis of pancreatitis after endoscopic retrograde cholangiopancreatography: A systematic review and meta-analysis.

Authors:  Ming-Hua Zheng; Mao-Bin Meng; Dian-Na Gu; Lei Zhang; Ai-Min Wu; Qian Jiang; Yong-Ping Chen
Journal:  Curr Ther Res Clin Exp       Date:  2009-08

Review 2.  Early successes and late failures in the prevention of post endoscopic retrograde cholangiopancreatography.

Authors:  John G Lieb; Peter V Draganov
Journal:  World J Gastroenterol       Date:  2007-07-14       Impact factor: 5.742

3.  Gabexate mesylate in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review and meta-analysis update.

Authors:  Ming-Hua Zheng; Jian-Ling Bai; Mao-Bin Meng; Yong-Ping Chen
Journal:  Curr Ther Res Clin Exp       Date:  2008-08

4.  Losartan to prevent hyperenzymemia after endoscopic retrograde cholangiopan-creatography: A randomized clinical trial.

Authors:  Tomas Sjöberg Bexelius; John Blomberg; Yun-Xia Lu; Hans-Olof Håkansson; Peter Möller; Carl-Eric Nordgren; Urban Arnelo; Jesper Lagergren; Mats Lindblad
Journal:  World J Gastrointest Endosc       Date:  2012-11-16

5.  Meta-analysis of prophylactic corticosteroid use in post-ERCP pancreatitis.

Authors:  Minghua Zheng; Jianling Bai; Bosi Yuan; Feng Lin; Jie You; Mingqin Lu; Yuewen Gong; Yongping Chen
Journal:  BMC Gastroenterol       Date:  2008-02-14       Impact factor: 3.067

Review 6.  Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis with rectal non-steroidal anti-inflammatory drugs.

Authors:  Tae Young Park; Hyoung-Chul Oh; Evan L Fogel; Glen A Lehman
Journal:  Korean J Intern Med       Date:  2020-04-29       Impact factor: 2.884
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.